We at AAPP envision a world where every individual with a psychiatric or neurologic disorder has a care team that includes a psychiatric pharmacist accountable for optimal medication therapy.
In much the same way, AAPP hopes to make a real impact by being part of a team of organizations who share a common vision of patient care and the profession. We encourage you to further investigate these partnerships to learn more about how AAPP is working to make an impact.
AllTrials calls for all past and present clinical trials to be registered and their full methods and summary results reported. AAPP supports the AllTrials proposal to require universal clinical trial registration.
Board certification through the Board of Pharmacy Specialties is recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels. Through rigorous standards, the BPS board certified pharmacist stands out as the most qualified to take on today’s expanding expectations of patients, physicians, employers and others who recognize the increasing need for a team approach to healthcare. AAPP is the sole provider of recertification education for the Board Certified Psychiatric Pharmacist (BCPP) credential from BPS.
The Council on Credentialing in Pharmacy (CCP) provides leadership, guidance, public information, and coordination for the profession of pharmacy's credentialing programs. The vision of CCP is that all credentialing programs in pharmacy will meet established standards of quality and contribute to improvement in patient care and the overall public health.
AAPP is a member of the FDA Network of Experts, a joint project for efficiently exchanging information and knowledge between the FDA and leaders in emerging fields of science and pioneering technologies, including neuropsychiatric pharmacy. The primary objective is to permit FDA rapid access to various scientific viewpoints from individual experts with experience in new medical technologies, with the mutual goal of having more innovative, safe, and effective neuropsychiatric medical products on the market.
The Gray Matters Coalition is a patient-centered interprofessional collaborative working to ensure equity in access and readiness to provide quality, wholistic care for older adults with brain health needs. The Coalition uses its collective voice to advocate for policies that support older adults with brain health needs. Members include: American Association for Geriatric Psychiatry (AAGP), American Association of Psychiatric Pharmacists (AAPP), American Psychiatric Association (APA), American Psychological Association (APA), American Geriatric Society (AGS), Gerontological Advanced Practice Nurses Association (GAPNA), National Hartford Center of Gerontological Nursing Excellence, American Psychiatric Nurses Association (APNA), American Society of Consultant Pharmacists (ASCP), The Society for Post-Acute and Long-term Care Medicine (AMDA)
The GTMRx Institute sponsors and supports multi-stakeholder activities that will encourage practice transformation, create pathways for dissemination of evidence and innovation and encourage payment and policy reform.
The Health Professions and Nursing Education Coalition (HPNEC) is an informal alliance of more than 60 organizations representing a variety of schools, programs, health professionals and students dedicated to educating professional health personnel. Together, the members of HPNEC advocate for adequate and continued support for the health professions and nursing workforce development programs authorized under Titles VII and VIII of the Public Health Service Act. The members of the Coalition believe these programs are essential to the development and training of tomorrow's health professionals and are critical to providing continued health services to underserved and minority communities.
JCPP was established in 1977 and serves as a forum on matters of common interest and concern to national organizations of pharmacy practitioners and invited liaison members.
The Mental Health Liaison Group (MHLG) is a coalition of national organizations representing consumers, family members, mental health and addiction providers, advocates, payers and other stakeholders committed to strengthening Americans’ access to mental health and addiction care. As trusted leaders in the field, our 60+ member organizations are dedicated to elevating the national conversation around mental health and addiction. Together, we work to advance federal policies that support prevention, early intervention, treatment and recovery services and supports.
In an effort to curb the misuse of opioids and enhance outcomes for affected individuals, families, and communities, AAPP has joined over 100 organizations to become a sponsoring member of the National Academy of Medicine's Action Collaborative on Countering the U.S. Opioid Epidemic. As a network organization, AAPP will provide input on Action Collaborative activities, network and share information with other network organizations, share resources and publications, and be invited to participate in shared solutions to the opioid crisis. In joining the action collaborative, AAPP committed to growing and educating the opioid use disorder treatment workforce through resources and educational activities as well as informing policymakers, other health care professionals, and legislators about the important role of the pharmacist in increasing access to care in the treatment of substance use disorders.
NAMI, the National Alliance on Mental Illness, is the nation’s largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness. AAPP contributes actively to NAMI through the creation and maintenance of the Mental Health Medication fact sheets (click on specific medications).
The Partnership for Part D Access is a collection of healthcare stakeholders, including patient groups, advocacy organizations and allied members of industry, who are committed to maintaining beneficiary access to the full range of available medications under Medicare Part D.
The Partnership to Amend 42 CFR Part 2 is a coalition of more than 50 national health care organizations representing a wide range of health care stakeholders, including patients, clinicians, hospitals, biopharmaceuticals, the mental health community, pharmacists, electronic health record vendors and payers, committed to aligning Part 2 with HIPAA to allow appropriate access to patient information that is essential for providing whole-person care.
The mission of the Patient Access to Pharmacists’ Care Coalition (PAPCC) is to develop and help enact a federal policy proposal that would enable Medicare beneficiary access to, and payment for, Medicare Part B services by state-licensed pharmacists in medically underserved communities. Our primary goal is to improve medically underserved seniors’ access to pharmacists’ services consistent with state scope of practice laws and regulations.
Founded in 2006, the Patient-Centered Primary Care Collaborative (PCPCC) is a not-for-profit membership organization dedicated to advancing an effective and efficient health system built on a strong foundation of primary care and the patient-centered medical home. The PCPCC is dedicated to transforming the U.S. health care system through delivery reform, payment reform, patient engagement, and benefit redesign.
Providers Clinical Support System (PCSS) is a SAMHSA-funded grant initiative that provides free trainings, resources, and clinical mentoring in the prevention and treatment of opioid use disorder. PCSS stakeholders include physicians, nurse practitioners, physician assistants, pharmacists, social workers, peer recovery coaches, nurses, and all health professionals involved with addressing the opioid healthcare crisis.
SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and administered by the American Psychiatric Association (APA). The APA works closely on this project with a team of experts from 30 other mental health organizations. This team includes individuals, families, clinical experts, peers, and policy makers.
The USP Convention is a governing body that includes more than 400 scientific, academic, practitioner, patient and consumer, and industry associations, as well as representatives of government agencies in the U.S. and around the world. At each USP Convention Meeting, Voting Members engage in dialogue about USP’s five-year strategic plan, and elect the USP’s Board of Trustees and the USP Council of Experts. The latter oversees USP’s Expert Committees, which are made up of nearly 1,000 expert volunteers who set quality standards for medicines, dietary supplements, food ingredients, and healthcare.
The Veterans Affairs system is the largest employer of psychiatric pharmacists. Additionally, the VA graduates the largest number of Post Graduate Year 2 psychiatric pharmacists of any employer. In the VA, Mental Health Clinical Pharmacy Specialists operate at the height of their license serving key roles in improving patient-centered care and medication outcomes by supporting the needs of the MH team, patients and caregivers in areas of medication management. AAPP works in partnership with the Veterans Affairs system to support and advance mental health clinical pharmacy practice.